Cancer. Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Ein abruptes Absetzen kann zu einem Entzugssyndrom führen. J Clin Oncol. 2009 Jul 22. Sowohl die Polycythaemia vera (PV) als auch die essentielle Thrombozythämie können im Verlauf zu einer sekundären Myelofibrose führen (Post-PV- bzw. [Medline]. 2002 Sep. 13(9):1370-7.
16(7):1160-8.

Savage KJ, Skinnider B, Al-Mansour M, Sehn LH, Gascoyne RD, Connors JM. Ann Oncol. N Engl J Med. State-of-the-art therapeutics: Hodgkin's lymphoma. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study. Re D, Kuppers R, Diehl V. Molecular pathogenesis of Hodgkin's lymphoma. J Clin Oncol. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Um diesen Artikel zu kommentieren, melde Dich bitte an. If you would rather reach us by phone, you can call the LLS IRC toll-free line at 1-800-955-4572 from 9am-9pm ET Monday-Friday or send us a message at https://www.lls.org/content/contact-us?UID=LLS-26-756.

J Clin Oncol. [Medline]. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. 25(25):3902-7. Blood. [Medline]. 2005 Oct 20. Specht L, Yahalom J, Illidge T, Berthelsen AK, Constine LS, Eich HT, et al. A prognostic score including these five parameters seems advisable in distinguishing different risk groups in PCNSL patients. The scores for all the factors are then added together to create the overall risk score. 116(21):185; (E2496) [abstract 415]. N Engl J Med. Cassaday RD, Fromm J, Cowan AJ, Libby EN III, Philip M, et al. 2010 Mar 11. Ann Oncol. Das P, Ng A, Constine LS, Hodgson DC, Mendenhall NP, Morris DE, et al. 2009 Feb 10. 36(3):270-81. Wedgwood A, Younes A. Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma. 67(1):19-30. 23(36):9208-18.

Eichenauer DA, Fuchs M, Pluetschow A, et al. 2012 May 1. Initial ist die PMF meist asymptomatisch. [Full Text]. SEER stat fact sheets: Hodgkin lymphoma. Zusätzlich zu genannten DNA-Veränderungen finden sich weitere sogenannte Passengermutationen, z.B. [1] Das mittleres Alter bei Diagnosestellung beträgt 60 bis 65 Jahre, jedoch sind 20 % der Patienten jünger als 65 Jahre und 11 % jünger als 46 Jahre. Heidenreich PA, Schnittger I, Strauss HW, et al. Each variable was assigned a value of either 0, if favorable, or 1, if unfavorable. Die PMF muss abgegrenzt werden von der sekundären Myelofibrose. It may cause more symptoms and health complications in a short amount of time. 2011 Aug 11. N Engl J Med. 34(3):211-27. Hentrich M, Maretta L, Chow KU, et al. Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO). J Pain Symptom Manage. Int J Radiat Oncol Biol Phys.

Published online Milano MT, Li H, Constine LS, Travis LB. Siegel RL, Miller KD, Jemal A.

Lyon, France: IARC Press; 2008. Sie kann sowohl mit einem Familien- als auch mit einem Fremdspender durchgeführt werden.

Hyperproliferative Phase (Thrombozytose, Leukozytose): Schwarz M, Riess H. Primäre Myelofibrose. Diseases & Conditions, 2002

[Medline]. [Medline]. Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

N Engl J Med. 118(17):4585-90. 1996. 30 (18):2183-9. ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma. Athanassios Argiris, MD Professor, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine [Medline]. 337(8737):320-2. Younes A, Gopal AK, Smith SE, Ansell SM, Rosenblatt JD, Savage KJ, et al. J Clin Oncol. That number matches the patient to one of the following five IPSS-R risk categories: The Leukemia & Lymphoma Society of Canada (LLSC) is a voluntary health agency dedicated to blood cancers. The values were then added together to arrive at a final score, which was tested in 105 assessable patients for which complete data of all five variables were available. Ann Oncol. [Medline]. Early-stage Hodgkin's lymphoma. 1991 Dec. 139(6):1259-65. 2006680-overview Ann Oncol. Post-ET-Myelofibrose). Version 1.2018 — December 20, 2017; Accessed: March 22, 2018.

[Medline].